Cargando…

Downregulation of T cell responses by antibodies to the T cell receptor

We have derived a T cell clone that recognizes and responds to three different types of antigen: self + X (fowl gamma globulin + H-2d), allo- H-2p,b, and minor lymphocyte-stimulating (Mlsa,d) determinants. Anti- TcR mAb and their F(ab')2 and Fab fragments were tested for their capacity to block...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1987
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188520/
https://www.ncbi.nlm.nih.gov/pubmed/3493319
_version_ 1782146427737079808
collection PubMed
description We have derived a T cell clone that recognizes and responds to three different types of antigen: self + X (fowl gamma globulin + H-2d), allo- H-2p,b, and minor lymphocyte-stimulating (Mlsa,d) determinants. Anti- TcR mAb and their F(ab')2 and Fab fragments were tested for their capacity to block the response of this clone. When responses were assayed on day 4 or later, addition of KJ16 or F23.1 mAb caused a marked inhibition of the response to each of the three antigens recognized by the clone. Responses measured at earlier time points however were unaffected or enhanced. This finding suggested that the inhibitory effects of anti-TcR mAb that followed the phase of enhancement might have reflected downregulation of the cells rather than simple blockade of TcR. In support of this possibility it was found that addition of anti-TcR mAb caused marked inhibition of the response of the clone to IL-2, i.e., a response that is not known to involve the TcR.
format Text
id pubmed-2188520
institution National Center for Biotechnology Information
language English
publishDate 1987
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21885202008-04-17 Downregulation of T cell responses by antibodies to the T cell receptor J Exp Med Articles We have derived a T cell clone that recognizes and responds to three different types of antigen: self + X (fowl gamma globulin + H-2d), allo- H-2p,b, and minor lymphocyte-stimulating (Mlsa,d) determinants. Anti- TcR mAb and their F(ab')2 and Fab fragments were tested for their capacity to block the response of this clone. When responses were assayed on day 4 or later, addition of KJ16 or F23.1 mAb caused a marked inhibition of the response to each of the three antigens recognized by the clone. Responses measured at earlier time points however were unaffected or enhanced. This finding suggested that the inhibitory effects of anti-TcR mAb that followed the phase of enhancement might have reflected downregulation of the cells rather than simple blockade of TcR. In support of this possibility it was found that addition of anti-TcR mAb caused marked inhibition of the response of the clone to IL-2, i.e., a response that is not known to involve the TcR. The Rockefeller University Press 1987-02-01 /pmc/articles/PMC2188520/ /pubmed/3493319 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Downregulation of T cell responses by antibodies to the T cell receptor
title Downregulation of T cell responses by antibodies to the T cell receptor
title_full Downregulation of T cell responses by antibodies to the T cell receptor
title_fullStr Downregulation of T cell responses by antibodies to the T cell receptor
title_full_unstemmed Downregulation of T cell responses by antibodies to the T cell receptor
title_short Downregulation of T cell responses by antibodies to the T cell receptor
title_sort downregulation of t cell responses by antibodies to the t cell receptor
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188520/
https://www.ncbi.nlm.nih.gov/pubmed/3493319